Koninklijke DSM NV
AEX:DSM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Koninklijke DSM NV
Cash from Financing Activities
Koninklijke DSM NV
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Koninklijke DSM NV
AEX:DSM
|
Cash from Financing Activities
-€645m
|
CAGR 3-Years
21%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Corbion NV
AEX:CRBN
|
Cash from Financing Activities
-€93.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Akzo Nobel NV
AEX:AKZA
|
Cash from Financing Activities
-€981m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
0%
|
|
Koninklijke DSM NV
Glance View
Koninklijke DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company is headquartered in Heerlen, Limburg and currently employs 21,358 full-time employees. The firm's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.
See Also
What is Koninklijke DSM NV's Cash from Financing Activities?
Cash from Financing Activities
-645m
EUR
Based on the financial report for Dec 31, 2022, Koninklijke DSM NV's Cash from Financing Activities amounts to -645m EUR.
What is Koninklijke DSM NV's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
14%
Over the last year, the Cash from Financing Activities growth was 34%. The average annual Cash from Financing Activities growth rates for Koninklijke DSM NV have been 21% over the past three years , 14% over the past five years .
